Nufarm on track to deliver strong underlying EBITDA growth, positive free cashflow and reduced leverage

Nufarm is today providing an update on FY26 performance.

Highlights

Underlying EBITDA (uEBITDA) expected to increase approximately 25% on the prior corresponding period (pcp)
Leverage expected to reduce significantly to approximately 2.0 times, reflecting improved earnings, cash generation and disciplined working capital management
Seed Technologies expected to deliver strong uEBITDA growth on pcp driven by Hybrid Seeds and Omega-3
Strategy refresh progressing to plan, with initiatives underway to simplify the business, lower costs and improve returns
On track to deliver $50 million of run-rate cost savings by the end of FY27.